In just over a year, histotripsy, the non-invasive ultrasound-based tumor-destroying treatment invented and developed at the University of Michigan, jumped from trial-stage hopeful to real-world therapy option that has benefited roughly 800 patients across the U.S. And the technology is already gaining footholds in other countries.
